Diffuse Hyperplastic Perilobar Nephroblastomatosis: Clinical Trials

2 trials for Diffuse Hyperplastic Perilobar Nephroblastomatosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Diffuse Hyperplastic Perilobar Nephroblastomatosis: new trials by email Literature Review of Diffuse Hyperplastic Perilobar Nephroblastomatosis trials Research Report on Diffuse Hyperplastic Perilobar Nephroblastomatosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
Dactinomycin, Doxorubicin Hydrochloride, Radiation Therapy - Adult Kidney Wilms Tumor, Beckwith-Wiedemann Syndrome
Phase 3CompletedChildren's Oncology Group2492009-08-242026-06-03
Study of Kidney Tumors in Younger Patients
Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis - Adult Cystic Nephroma, Anaplastic Kidney Wilms Tumor
CompletedChildren's Oncology Group80002006-02-272026-05-18

Narrower conditions

Wilms Tumor (2)  ·  Angiolipoma (1)  ·  Beckwith-Wiedemann Syndrome (1)  ·  Carcinoma, Renal Cell (1)  ·  Kidney Neoplasms (1)  ·  Nephroma, Mesoblastic (1)  ·  Oncocytoma, renal (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genetic Diseases, Inborn (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Complex and Mixed (2)  ·  Neoplastic Syndromes, Hereditary (2)  ·  Urogenital Diseases (2)  ·  Urogenital Neoplasms (2)  ·  Urologic Diseases (2)  ·  Urologic Neoplasms (2)

Interventions

Dactinomycin (1)  ·  Doxorubicin (1)  ·  Radiation (1)  ·  Radiotherapy (1)  ·  Vincristine (1)

Sponsors

Children's Oncology Group (2)

Countries

Australia (2)  ·  Canada (2)  ·  Israel (2)  ·  New Zealand (2)  ·  Puerto Rico (2)  ·  United States (2)  ·  Switzerland (1)

Top investigators

Elizabeth A Mullen (1)  ·  Peter F Ehrlich (1)

Results publications

PMID 32267967, PMID 35072864, PMID 37933882, PMID 38396300, PMID 42657661

NIH funding

U10CA098543 (2), U10CA180886 (2), UG1CA189958 (1)